Delivery Order SPE2DB22D3004-SPE2DB25FPN60
Award Date
2/14/25
Potential Completion Date
2/18/25
Potential Value
$12K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, SPE2DB22D2206|SPE2DB23FKK71, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $87,575.38 firm fixed-price delivery order is for the pharmaceutical product ELIQUIS 5 MG TABLET 60S, with a completion date of September 20, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs,...
This federal contract award, with ID SPE2DB22D2206|SPE2DB24FFE88, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $17,479.18 Firm Fixed Price delivery order contract is for the pharmaceutical product ELIQUIS 5 MG TABLET 60S. The ultimate completion date for this contract is January 23, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical...
This federal contract award, with ID SPE2DB24D1205|SPE2DB25FCTYF, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $12,329.21 firm fixed-price delivery order is for the supply of 4567249020 ELIQUIS 5 MG TABLET 60S, with a completion date of February 13, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, including the military and...
This federal contract award (SPE2DB20D1004|SPE2DB22FE8E6) was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of ELIQUIS 5 MG TABLET 60S. The $12,440.30 firm fixed price contract has a completion date of November 3, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a...
This federal contract award, identified as SPE2DB20D2104|SPE2DB25FMGPY, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order valued at $1,474.20, is for the delivery of the pharmaceutical product ELIQUIS 2.5 MG TABLET 60S. The contract does not have a set-aside designation, indicating it was an open competition. AmerisourceBergen Drug Corp is the prime...
This federal contract award, with ID SPE2DB20D3103|SPE2DB25FL9S5, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $12,848.25 firm fixed-price delivery order is for the supply of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of December 12, 2024 and was awarded on December 11, 2024. No set-aside designation was used for this contract. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award, with ID SPE2DB20D1004|SPE2DB24FF2N5, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $6,291.50 Firm Fixed Price Delivery Order is for the supply of 4563370662 ELIQUIS 2.5 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of January 22, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
This federal contract award, SPE2DB22D3004|SPE2DB25FPM16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,457.00 firm fixed-price delivery order is for the supply of ELIQUIS 5 MG TABLET 60S, with a completion date of February 12, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, with ID SPE2DB22D3501|SPE2DB24FVQ92, was granted by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,798.33, is for the delivery of 4564591744 ELIQUIS 5 MG TABLET 60S. The contract has an ultimate completion date of May 14, 2024 and is a firm fixed-price delivery order. This contract is not designated as a set-aside and represents an open competition...
This federal contract award, with an ID of SPE2DB22D3004|SPE2DB24FQJ83, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $22,545.27, is for the delivery of 4564618105 ELIQUIS 5 MG TABLET 60S. This is a firm fixed-price Delivery Order contract with a completion date of May 16, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...